Fort Lauderdale, FL, Sept. 26, 2025 (GLOBE NEWSWIRE) — Drugs Made In America Acquisition II Corp. (Nasdaq: DMIIU) (the “Company”) today announced that it closed its initial public offering of 50,000,000 units at $10.00 per unit. The gross proceeds from the offering were $500 million before deducting underwriting discounts and offering expenses. The units began trading on The Nasdaq Global Market (“Nasdaq”) under the ticker symbol “DMIIU” on September 25, 2025.
Drugs Made In America Acquisition II Corp. Announces Closing of $500,000,000 Initial Public Offering
